compound 39 [PMID: 36127295]   Click here for help

GtoPdb Ligand ID: 12236

Compound class: Synthetic organic
Comment: This compound was designed as an inhibitor of eukaryotic translation initiation factor 2 alpha kinase 4 (a.ka. GCN2) [1], for potential anti-tumour efficacy.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 8
Hydrogen bond donors 2
Rotatable bonds 6
Topological polar surface area 138.23
Molecular weight 527.44
XLogP 4.47
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CNC(=O)[C@]1(C)CC[C@H](C1)Nc1ncc2c(n1)n(nc2Br)c1ccc(cc1)c1nnc(s1)C
Isomeric SMILES Brc1nn(c2ccc(c3nnc(C)s3)cc2)c2c1cnc(N[C@@H]1CC[C@](C(=O)NC)(C)C1)n2
InChI InChI=1S/C22H23BrN8OS/c1-12-28-29-19(33-12)13-4-6-15(7-5-13)31-18-16(17(23)30-31)11-25-21(27-18)26-14-8-9-22(2,10-14)20(32)24-3/h4-7,11,14H,8-10H2,1-3H3,(H,24,32)(H,25,26,27)/t14-,22-/m1/s1
InChI Key ASGMFNBUXDJWJJ-JLCFBVMHSA-N
References
1. Jackson JJ, Shibuya GM, Ravishankar B, Adusumilli L, Bradford D, Brockstedt DG, Bucher C, Bui M, Cho C, Colas C et al.. (2022)
Potent GCN2 Inhibitor Capable of Reversing MDSC-Driven T Cell Suppression Demonstrates In Vivo Efficacy as a Single Agent and in Combination with Anti-Angiogenesis Therapy.
J Med Chem, 65 (19): 12895-12924. [PMID:36127295]